Several investigators have reported favourable clinical outcomes after transcatheter aortic valve implantation (TAVI)1-7. These studies, however, are characterised by a great deal of heterogeneity involving the definition of clinical endpoints. Several organisations with an interest in TAVI have alluded to the need for standardising reporting practices8-11. The purpose of this editorial is to create awareness of the challenges associated with clinically assessing TAVI and, more importantly, to call for consistency among endpoint definitions used for reporting the results of transcatheter valvular interventions.
One complicating factor when trying to evaluate available data stems from the fact that the ...
TAVR in sarcopaenia; CCTA or TEE in LAAC; Iintravascular lithotripsy, read the new issue
(CT scans of a sarcopaenic patient)
October 18, 2019